Effect of probenecid on depolarizations evoked by N-methyl D-aspartate (NMDA) in the rat striatum

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 355, Issue 1, 1996, Pages 36-42

  Urenjak, Jutta ^a   Obrenovitch, Tihomir P ^b   Zilkha, Elias ^b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

DC potential; Kynurenic acid; Microdialysis; N methyl D aspartate; Organic acid transport; Probenecid

Indexed keywords

CARBOXYLIC ACID; KYNURENIC ACID; N METHYL DEXTRO ASPARTIC ACID; PROBENECID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPOLARIZATION; DIRECT CURRENT; HYPERPOLARIZATION; INTRACEREBRAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; RAT;

EID: 0031026701     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00004915     Document Type: Article

References (58)

1. Assaf HM, Ricci AJ, Whittingham TS, LaManna IC, Ratcheson RA, Lust WD (1990) Laclate compartmentation of hippocampal slices: evidence for a transporter. Metab Brain Dis 5:143-154
2. Benveniste H, Drejer J, Schousboe A, Diemer NH (1987) Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fiber through the dorsal hippocampus in the rat. J Neurochem 49:729-734
3. Bigge CF, Johnson G, Taylor CP, Welty D (1993) Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist. International Patent Publication. WO 93/04688 (18 March 1993)
4. Bliss TVP, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39
5. Bureŝ J, Buresová O, Krivánek J (1974) The mechanisms and applications of Leao's spreading depression of electroencephalographic activity. Academic Press, New York
6. Carpenedo R, Chiarugi A, Russi P, Lombardi G, Carla V, Pellicciari R, Mattoli L, Moroni F (1994) Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities. Neuroscience 61:237-244
7. Carter AJ (1995) Antagonists of the NMDA receptor-channel complex and motor coordination. Life Sci 57:917-929
8. Chiarugi A, Carpenedo R, Molina MT, Mattoli L, Pellicciari R, Moroni F (1995) Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/ or kynureninase. J Neurochem 65:1176-1183
9. Cumming P, Brown E, Damsma G, Fibiger H (1992) Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum: An in vivo microdialysis study. J Neurochem 59:1905-1914
10. Duval D, Roome N, Gauffeny C, Nowicki JP, Scatton B (1992) SL 82.0715, an NMDA antagonist acting at the polyamine site, does not induce neurotoxic effects on rat cortical neurons. Neurosci Lett 137:193-197
11. Fix AS, Long GG, Wozniak DF, Olney JW (1994) Pathomorphologic effects of N-methyl-D-aspartate antagonists in the rat posterior cingulate/retrosplenial cerebral cortex: a review. Drug Develop Res 32:147-152
12. + pump activation in rat hippocampal neurons. J Neurophysiol 68:28-35
13. Gault LM, Lin C-W, Lamanna JC, Lust WD (1994) Changes in energy metabolites, cGMP and intracellular pH during cortical spreading depression. Brain Res 641:176-180
14. Ghribi O, Callebert J, Plotkine M, Boulu RG (1994) Effect of kynurenic acid on the ischemia-induced accumulation of glutamate in rat striatum. Neuroreport 5:435-437
15. Hargreaves RJ, Rigby M, Smith D, Hill RG (1993) Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology. Br J Pharmacol 110:36-42
16. Johnson GA, Benveniste H, Black RD, Hedlund LW, Maronpot RR, Smith BR (1993) Histology by magnetic resonance microscopy. Magn Reson Q 9:1-30
17. Katayama Y, Tamura T, Becker DP, Tsubokawa T (1992) Early cellular swelling during cerebral ischemia in vivo is mediated by excitatory amino acids released from nerve terminals. Brain Res 577:121-126
18. Katayama Y, Kawamata T, Maeda T, Ishikawa K, Tsubokawa T (1994) Inhibition of the early phase of free fatty acid liberation during cerebral ischemia by excitatory amino acid antagonist administered by microdialysis. Brain Res 635:331-334
19. Kawamata T, Katayama Y, Hovda DA, Yoshino A, Becker DP (1995) Lactate accumulation following concussive brain injury - The role of ionic fluxes induced by excitatory amino acids. Brain Res 674:196-204
20. Kemp JA, Foster AC, Leeson PD, Priestley T, Tridgett R, Iversen LL, Woodruff GN (1988) 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc Natl Acad Sci USA 85:6547-6550
21. Kuhr WG, Van den Berg CJ, Korf J (1988) In vivo identification and quantitative evaluation of carrier-mediated transport of lactate at the cellular level in the striatum of conscious, freely moving rats. J Cereb Blood Flow Metab 8:848-856
22. Lash LH, Anders MW (1989) Uptake of nephrotoxic S-conjugates by isolated rat renal proximal tubular cells. J Pharmacol Exp Ther 248:531-537
23. Lauritzen M (1994) Pathophysiology of the migraine aura: the spreading depression theory. Brain 117:199-210
24. 2+ response to NMDA application investigated with microdialysis of rabbit hippocampus in vivo. Acta Neurobiol Exp 52:83-91
25. Luo D, Leung E, Vincent SR (1994) Nitric oxide-dependent efflux of cGMP in rat cerebellar cortex: an in vivo microdialysis study. J Neurosci 14:263-271
26. Martin DC, Plagenhoef M, Abraham J, Dennison RL, Aronstam RS (1995) Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors. Biochem Pharmacol 49:809-817
27. Martinez-Fong D, Rosales MG, Gongora-Alforo JL, Hernandez S, Aceves J (1992) NMDA receptor mediates dopamine release in the striatum of unanesthetized rats as measured by brain microdialysis. Brain Res 595:309-315
28. McDonald IA, Baron BM (1993) Potentiation of NMDA antagonists. International Patent Publication. WO 93/12780 (8 July 1993)
29. Meldrum BS (1994) The role of glutamate in epilepsy and other CNS disorders. Neurology 44 [Suppl 8]:S14-S23
30. Miller JM, MacGarvey U, Beal MF (1992) The effect of peripheral loading with kynurenine and probenecid on extracellular striatal kynurenic acid concentrations. Neurosci Lett 146:115-118
31. Moroni F, Lombardi G, Carla V, Moneti G (1984) The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain. Brain Res 295:352-355
32. Moroni F, Russi P, Lombardi G, Beni M, Carlà V (1988) Presence of kynurenic acid in the mammalian brain. J Neurochem 51:177-180
33. Muir KW, Lees KR (1995) Clinical experience with excitatory amino acid antagonist drugs. Stroke 26:503-513
34. Nicholson C, Phillips JM (1981) Ion diffusion modified by tortuosity and volume fraction in the extracellular microenvironment of the rat cerebellum. J Physiol (Lond) 321:225-257
35. Nozaki K, Beal MF (1992) Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats. J Cereb Blood Flow Metab 12:400-407
36. Obrenovitch TP, Richards DA, Sarna GS, Symon L (1993) Combined intracerebral microdialysis and electrophysiological recording: methodology and applications. J Neurosci Methods 47:139-145
37. Obrenovitch TP, Urenjak J, Zilkha E (1994) Intracerebral microdialysis combined with recording of extracellular field potential: a novel method for investigation of depolarizing drugs in vivo. Br J Pharmacol 113:1295-1302
38. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, London
39. Penit JS, Jard S, Benda P (1974) Probenecid sensitive 3′,5′-cyclic AMP secretion by isoproterenol stimulated glial cells in cultures. FEBS Lett 41:156-160
40. Russi P, Alesiani M, Lombardi G, Davolio P, Pellicciari R, Moroni F (1992) Nicotinylalanine increases the formation of kynurenic acid in the brain and antagonizes convulsions. J Neurochem 59:2076-2080
41. Santamaría A, Ríos C, Solís-Hernández F, Ordaz-Moreno J, González-Reynoso L, Altagracia M, Kravzov J (1996) Systemic DL-kynurenine and probenecid pretreatment attenuates quinolinic acid-induced neurotoxicity in rats. Neuropharmacology 35:23-28
42. Sarna GS, Hutson PH, Tricklebank MD, Curzon G (1983) Determination of brain 5-hydroxytryptamine turnover in freely moving rats using repeated sampling of cerebrospinal fluid. J Neurochem 40:383-388
43. Sebens JB, Korf J (1975) Cyclic AMP in cerebrospinal fluid: accumulation following probenecid and biogenic amines. Exp Neurol 46:333-344
44. Sheardown MJ (1993) The triggering of spreading depression in the chicken retina: a pharmacological study. Brain Res 607:189-194
45. Stone TW (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45:309-379
46. Stone TW, Connick JH (1985) Quinolinic acid and other kynurenines in the central nervous system. Neuroscience 15:597-617
47. +. Proc Natl Acad Sci USA 87:6445-6449
48. Taylor CP, Vartanian MG (1992) Probenecid pretreatment enhances anticonvulsant action of NBQX in mice. Eur J Pharmacol 213:151-153
49. Taylor DL, Obrenovitch TP, Gotoh M, Symon L (1994) Inhibition of spreading depression by probenecid. In: Rose FC (ed) New advances in headache research, vol 4. Smith-Gordon, London, pp 291
50. Taylor DL, Obrenovitch TP, Symon L (1996) Changes in extracellular acid-base homeostasis in cerebral ischaemia. Neurochem Res 21:1019-1028
51. Thompson SM, Prince DA (1986) Activation of electrogenic sodium pump in hippocampal CA1 neurons following glutamate-induced depolarization. J Neurophysiol 56:507-522
52. Thorn NA, Nielsen FS, Jeppesen CK (1991) Characteristics of ascorbic acid uptake by isolated ox neurohypophyseal nerve terminals and the influence of glucocorticoid and tri-iodothyronine on uptake. Acta Physiol Scand 141:97-106
53. Traynelis SF, Cull-Candy S (1990) Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons. Nature 345:347-350
54. Urenjak J, Zilkha E, Gotoh M, Obrenovitch TP (1996a) Effect of extracellular acidosis on N-methyl-D-aspartate (NMDA)-evoked responses in vivo. Br J Pharmacol 118[Suppl]:45P
55. Urenjak J, Zilkha E, Obrenovitch TP (1996b) Origin of depolarizations evoked in the rat striatum by competitive inhibition of glutamate uptake with L-trans-pyrrolidine-2,4-dicarboxylate (L-trans-PDC). Br J Pharmacol 117[Suppl.]:67P
56. Vécsei L, Miller J, MacGarvey U, Beal MF (1992) Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain. Brain Res Bull 26:233-238
57. Willetts J, Balster RL, Leander JD (1990) The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 11:423-428
58. Watson GB, Hood WF, Monahan JB, Lahthorn TH (1988) Kynurenate antagonizes actions of NMDA through glycine-sensitive receptor. Neurosci Res Commun 2:169-174